Image

Middle East and Africa Heparin Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Middle East and Africa Heparin Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • MEA
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Middle East and Africa Heparin Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 153.20 USD Million
Diagram Market Size (Forecast Year) USD 285.67 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Middle East and Africa Heparin Market, By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), Mode of Administration (Oral, Parenteral), Source (Bovine, Porcine), Ingredients (Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others),  Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others),  Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others),   Type (Generics, Brands),  Container (Bottles, Bags, Vials, Others),  Packaging (Glass, Plastic),  End-User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy, Others) - Industry Trends and Forecast to 2030.

Middle East and Africa Heparin Market

Middle East and Africa Heparin Market Analysis and Size

As countries in the Middle East and Africa continue to invest in healthcare infrastructure and services, there is a growing ability to diagnose and treat various medical conditions, including cardiovascular diseases and thrombotic disorders, for which heparin is commonly used. The region is witnessing an aging population, which is more susceptible to various medical conditions that require anticoagulant therapy. Heparin is widely used in the management of thromboembolic diseases, which become more common with age.

Data Bridge Market Research analyses that the Middle East and Africa heparin market which was USD 153.20 million in 2022, is expected to reach USD 285.67 million by 2030, and is expected to undergo a CAGR of 8.1% during the forecast period. This indicates the market value. “Unfractionated Heparin” dominates the product type segment of the Middle East and Africa heparin market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Heparin Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), Mode of Administration (Oral, Parenteral), Source (Bovine, Porcine), Ingredients (Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others),  Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others),  Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others),   Type (Generics, Brands),  Container (Bottles, Bags, Vials, Others),  Packaging (Glass, Plastic),  End--User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy, Others)

Countries Covered

Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Market Players Covered

Sanofi (France), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland) , Mylan N.V.(U.S.), Aspen Holdings (South Africa), Fresenius Kabi AG (Germany), Hebei Changshan Biochemical Pharmaceutical Co. Ltd.(China), Hikma Pharmaceuticals PLC (U.K.), LEO Pharma A/S (Denmark)

Market Opportunities

  • Rising incidence of chronic diseases
  • Rising technological advancements
  • Rising R & D activities

Market Definition

The heparin market is the global pharmaceutical and healthcare sector that involves the production, distribution, and use of heparin, which is an anticoagulant medication. Heparin is a naturally occurring substance found in the body and is also produced synthetically for medical purposes. It is commonly used to prevent or treat conditions characterized by abnormal blood clotting, such as deep vein thrombosis (DVT), pulmonary embolism, and certain cardiovascular procedures such as open-heart surgery.

Middle East and Africa Heparin Market Dynamics

Drivers

  • Increasing Healthcare Expenditure

As countries in the Middle East and Africa continue to invest in healthcare infrastructure and services, there is a growing ability to diagnose and treat various medical conditions, including cardiovascular diseases and thrombotic disorders, for which heparin is commonly used

  • Rising Incidence of Chronic Diseases

The prevalence of chronic diseases such as heart diseases, diabetes, and cancer is increasing in the Middle East and Africa. Heparin is often used as an anticoagulant in the treatment of patients with these conditions

Opportunities

  • Rising Research and Development

Opportunities exist for pharmaceutical companies and research institutions in the MEA region to conduct research on heparin and its potential applications. This can lead to the development of innovative formulations and delivery methods

Restraint/Challenge

  • Regulatory Hurdles

Meeting regulatory requirements for the production, import, and distribution of pharmaceutical products, including heparin, can be complex in some MEA countries. Differing regulatory standards and requirements across countries can present challenges for manufacturers and distributors seeking to enter multiple markets

This Middle East and Africa heparin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa heparin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Recent Development

  • In August 2022, FDA approved Momenta Pharmaceuticals, Inc.'s M-Enoxaparin product. Together with Sandoz, the generics arm of Novartis AG, Momenta is creating M-Enoxaparin, a technology-enhanced generic version of lovenox

Middle East and Africa Heparin Market Scope

The Middle East and Africa heparin market is segmented on the basis of product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, type, container, packaging, end-user, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-Low Molecular Weight Heparin (ULMWH)

Mode of Administration

  • Oral
  • Parenteral

Source

  • Bovine
  • Porcine

Ingredients

  • Sodium
  • Calcium
  • Others

Availability

  • Raw
  • Processed

Treatment

  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Arterial Thromboembolism
  • Others

Application

  • Pre-Surgical Procedures
  • Post-Surgical Procedures
  • Kidney Dialysis
  • Diagnostic Tests
  • Others

Therapeutics

  • Cardiovascular
  • Respiratory
  • Oncology
  • Nephrology
  • CNS
  • Others

Strength

  • 10 Unit
  • 100 Unit
  • 1000 Unit
  • 5000 Unit
  • 10000 Unit
  • 25000 Unit
  • Others

Type

  • Generics
  • Brands

Container

  • Bottles
  • Bags
  • Vials
  • Others

Packaging

  • Glass
  • Plastic

End User

  • Hospitals
  • Clinics
  • Homecare
  • Ambulatory Surgical Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy and Drug Store
  • Online Pharmacy
  • Others

Middle East and Africa Heparin Market Regional Analysis/Insights

Middle East and Africa heparin market  is analyzed, and market size insights and trends are provided by product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, type, container, packaging, end-user, and distribution channel as referenced above.

The countries covered in the Middle East and Africa heparin market report are Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Saudi Arabia dominates the heparin market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to rising healthcare expenditure will further propel the market's growth rate in this region. In addition, favorable health remuneration policies, rise in chronic wounds, and a growing elderly population will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The heparin market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for heparin market impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the heparin market. The data is available for historic period 2015 to 2020

Competitive Landscape and Heparin Market Share Analysis

The heparin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to heparin market.

Some of the major players operating in the heparin market are:

  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Mylan N.V.(U.S.)
  • Aspen Holdings (South Africa)
  • Fresenius Kabi AG (Germany)
  • Hebei Changshan Biochemical Pharmaceutical Co. Ltd.(China)
  • Hikma Pharmaceuticals PLC (U.K.)
  • LEO Pharma A/S (Denmark)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Middle East and Africa Heparin Market will be worth USD 285.67 million by 2030.
The Middle East and Africa Heparin Market growth rate is 8.1% during the forecast period.
The Increasing Healthcare Expenditure and rising Incidence of Chronic Diseases are the growth drivers of the Middle East and Africa Heparin Market.
The product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, type, container, packaging, end-user, and distribution channel are the factors on which the Middle East and Africa Heparin Market research is based.
FDA approved Momenta Pharmaceuticals, Inc.'s M-Enoxaparin product and Together with Sandoz, the generics arm of Novartis AG, Momenta is creating M-Enoxaparin, a technology-enhanced generic version of lovenox are the latest developments in the Middle East and Africa Heparin Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials